Wendy future of retail top

dermatology

Walgreens teams up with The Skin Cancer Foundation

Walgreens teams up with The Skin Cancer Foundation

NEW YORK — Walgreens has joined The Skin Cancer Foundation on the road this year in support of its Destination: Healthy Skin Program — a national effort to educate consumers about the importance of effective sun protection for skin cancer prevention, and the importance of early detection. “As people spend more time outside enjoying their

Allergan to acquire Vitae Pharmaceuticals

Allergan to acquire Vitae Pharmaceuticals

DUBLIN, Ireland — Allergan plc plans to buy clinical-stage biotech firm Vitae Pharmaceuticals Inc. in a cash deal valued at $639 million. Allergan said the acquisition will bolster its dermatology product pipeline with the addition of VTP-43742, a Phase 2 orally active RORγt inhibitor for the potential treatment of psoriasis and other autoimmune disorders. The

Mylan to acquire Renaissance topicals business

Mylan to acquire Renaissance topicals business

PITTSBURGH — Mylan N.V. has entered an agreement to buy the nonsterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings LLC for $950 million in cash. Mylan said Friday that the Renaissance business, which has about 1,200 employees and posted sales of $370 million in 2015, will bring 25 branded and generic topical products,

PP_1170x120_10-25-21